DISCLOSURE REGARDING THE COMPANY Sample Clauses

DISCLOSURE REGARDING THE COMPANY. The Company is a publicly reporting corporation subject to the reporting requirements of the Securities Exchange Act of 1934 and is current in its filing obligations. Copies of the Company’s periodic filings with the SEC can be found at wxx.xxx.xxx.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
DISCLOSURE REGARDING THE COMPANY. The Sellers shall, upon reasonable request, provide the Purchaser Group with such information and documentation concerning the Company and the Sellers as may be reasonably necessary for the Purchaser Group to verify performance of and compliance with the representations, warranties, covenants and conditions of the Sellers contained herein.
Sample 1
DISCLOSURE REGARDING THE COMPANY. The Company ROYALTECH CORP IS A DELAWARE COMPANY EXISTED SINCE APRIL, 2004, WHOSE BUSINESS OBJECTIVE IS TO PROFIT FROM DEVELOPMENT AND MARKETING OF INNOVATIVE BIOMEDICAL PRODUCTS. The company has recruited a scientist who possesses the technology know-how and patents of several biomedical techniques (China Patent No. CN 14835A, CN 1428436A) , some of which have recently been commercialized and marketed in two regions in China (Details, see the Addendum, “Kitsinfo”). The biotechnological innovations are in the field of clinical diagnostic and treatment monitoring (method and kits) for hepatocacinma, gastrocacinoma, diabetic and hepatobilary disorders (see the Addendum “Kitsinfo”). The diagnosis and treatment of these disorders are currently great challenges to the medical field and have tremendous economic impart worldwide. The marketing 0000 XXXXXXXXXX #000X, XXXXXXXX, XXXXXX, XXXXXX , X0X 0X0 000 XXXXXXXXX XXXXXXXXXXXX CENTER, NEWARK, DE, 19711, USA TEL: (000) 000-0000, FAX: 000-0000000, EMAIL: XXXXXXXXX@XXXXXX.XXX ROYALTECH CORP. focus of the company will be initially in China, and then into East/South Asian countries, (where the most need for two of the Products are expected based on the worldwide reports of high rates of the diseases), and Western countries. The goal of the Company is to establish itself, in these areas, as a major force in promoting the innovative biotech products in particularly the medical diagnosis, and management by bringing together its network of financing sources, management expertise, the latest proprietary techniques and extensive local medical contacts. Business Strategy RTC plans to develop its business mostly through acquisitions and/or joint ventures with local participants, in which the Company will have substantial equity and management control. Priority will be given to the more advanced biotech products that have great market demands, and pre-feasibility study work has already been done. The objective is to become the owner of the proprietary innovative products (manufacture and or marketing rights) in the shortest term possible. With profit potential adequately demonstrated and funding available, a profitable operation can be seen in as quick as twelve months. The short-term goal is to achieve Nasdaq OTC listing and market expansion in China. Accomplishment To-Date As its initial foray into the business, RTC has reached an agreement to recruit the patent owner as the director of the Company, and would acquire the rig...
Sample 1

Related to DISCLOSURE REGARDING THE COMPANY

  • Information Concerning the Company Buyer has conducted its own due diligence with respect to the Company and its liabilities and believes it has enough information upon which to base an investment decision in the Stock. Buyer acknowledges that Seller has made no representations with respect to the Company, its status, or the existence or non-existence of liabilities in the Company except as explicitly stated in this Agreement. Buyer is taking the Company “as is” and acknowledges and assumes all liabilities of the Company.

  • Representations and Warranties Regarding the Company (a) The Company represents and warrants to, and agrees with, the several Underwriters, as of the date hereof and as of the Closing Date and as of each Option Closing Date, if any, as follows:

  • Representations and Warranties of the Company Regarding the Offering (a) The Company represents and warrants to, and agrees with, the several Underwriters, as of the date hereof and as of the Closing Date (as defined in Section 4(d) below) and as of each Option Closing Date (as defined in Section 4(b) below), as follows:

  • Conduct of Business by the Company Pending the Closing The Company agrees that, between the date of this Agreement and the Effective Time, except as set forth in Section 6.01 of the Company Disclosure Schedule or as expressly contemplated by any other provision of this Agreement, unless Parent shall otherwise agree in writing, (x) the respective businesses of the Company and the Company Subsidiaries shall be conducted only in, and the Company and the Company Subsidiaries shall not take any action except in, the ordinary course of business consistent with past practice and (y) the Company shall use all reasonable efforts to keep available the services of such of the current officers, significant employees and consultants of the Company and the Company Subsidiaries and to preserve the current relationships of the Company and the Company Subsidiaries with such of the corporate partners, customers, suppliers and other persons with which the Company or any Company Subsidiary has significant business relations in order to preserve substantially intact its business organization. By way of amplification and not limitation, except as set forth in Section 6.01 of the Company Disclosure Schedule or as expressly contemplated by any other provision of this Agreement, neither the Company nor any Company Subsidiary shall, between the date of this Agreement and the Effective Time, directly or indirectly, do, or agree to do, any of the following without the prior written consent of Parent, which consent shall not be unreasonably withheld or delayed:

  • Representations and Warranties Regarding the Contracts in the Aggregate Seller represents and warrants, as of the execution and delivery of this Agreement and as of the Closing Date, that:

  • Representations and Warranties Regarding the Seller The Seller represents, warrants and covenants to the Purchaser that as of the date hereof and as of each Closing Date:

  • Representations and Warranties Regarding the Servicer The Servicer represents and warrants to the Trust, the Indenture Trustee and the Noteholders that:

  • Representations and Warranties Regarding the Contract Files Seller represents and warrants as of the execution and delivery of this Agreement and as of the Closing Date, in the case of the Initial Contracts, and as of the applicable Subsequent Transfer Date, in the case of Subsequent Contracts, that:

  • REPRESENTATIONS AND WARRANTIES CONCERNING THE COMPANY The Company and Seller jointly and severally represent and warrant to the Purchaser that the statements contained in this Section 5 are correct and complete as of the date of this Agreement and will be correct and complete as of the Closing Date (as though made then and as though the Closing Date were substituted for the date of this Agreement throughout this Section 5).

  • Conduct of Business Pending the Closing From and after the execution and delivery of this Agreement and until the Closing Date, except as otherwise provided by the prior written consent or approval of the Buyer:

Time is Money Join Law Insider Premium to draft better contracts faster.